Clene Welcomes New Shareholder Base and Announces Closing of Underwritten Public Offering of $40 Million
Investment led by Vivo Capital with participation from SymBiosis, Acuta Capital Partners, AIGH Capital, Serrado Capital LLC, and other new biotech investors,…